Our budget impact analysis model demonstrates that increasing treatment rate for people living with ADHD would realise healthcare and social savings by reducing the impact of the comorbidities associated with the condition. This would benefit people living with ADHD and their families, as well as the healthcare systems and societies in which they live.
To achieve these benefits, Takeda recommends three key recommendations that policymakers should implement:
In some countries this may require investment into increased capacity in ADHD services and updates to local treatment protocols.
These should include ambitious but achievable targets and a clear implementation plan.
These data should be reported on a regular basis and should include healthcare and wider social metrics to demonstrate the value of investment in increasing ADHD treatment rates.
Read our ‘Attention on ADHD’ report, which uses a new budget impact analysis model commissioned by Takeda to show the cost of untreated ADHD and the value of increasing treatment rates to realise healthcare and social savings.
Download our infographic, which summarises the key findings from the report.
